Search Press releases Keywords From To 10 Dec 2021 UCB announces positive Phase 3 results for rozanolixizumab in generalized myasthenia gravis Read More 3 Dec 2021 Disposals of own shares Read More 3 Dec 2021 UCB to present new data at the American Epilepsy Society 75th Annual Meeting 2021 reinforcing long-standing commitment to advancing epilepsy treatment and care Read More 2 Dec 2021 UCB Announces Global Partnership to Bring Disease-Modifying Therapies to People Living with Parkinson’s Disease Read More 30 Nov 2021 UCB and Chiesi enter global license agreement for zampilimab a novel monoclonal antibody for fibrotic lung diseases Read More 26 Nov 2021 Disposals of own shares Read More Pagination First page Previous page Previous … Page 47 Page 48 Page 49 Page 50 Current page 51 Page 52 Page 53 Page 54 Page 55 … Page 51 of 63 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
